Hyundai Bioscience announced on April 25th that its clinical development plan of oral “Niclosamide Metabolic Anticancer Drug” …
![Niclosamide-based metabolic anticancer drug development](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/pexels-photo-7230183.jpeg?resize=400%2C267&ssl=1)
![Niclosamide-based metabolic anticancer drug development](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/pexels-photo-7230183.jpeg?resize=400%2C267&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Hyundai Bioscience announced on April 25th that its clinical development plan of oral “Niclosamide Metabolic Anticancer Drug” …
Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced it received …
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the first subject has been …